Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-27

Clinical Trial Update: Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic drug interaction study evaluating co-administration of valsartan, hydrochlorothiazide, and amlodipine in patients with hypertension; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIOVAN (valsartan)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED